Nivaquine Syrup

About Nivaquine 80 mg/5 ml Syrup

Nivaquine Syrup is a chloroquine phosphate medicine in a liquid form. It is used for malaria and some other conditions as decided by a doctor.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Nivaquine 80 mg/5 ml Syrup?

Nivaquine Syrup is a medicine with chloroquine phosphate as its active ingredient, supplied in a liquid form by Synovia Pharma PLC. It belongs to a group of medicines called anti-malarials. Chloroquine is used to treat and prevent malaria, and it is also prescribed for amoebic liver infections and certain long-term inflammatory conditions such as rheumatoid arthritis and lupus. It works against the malaria parasite in the blood. The syrup is available in a strength of 80 mg per 5 ml. Like all medicines, it should only be used when prescribed by a doctor.

Uses of Nivaquine

Chloroquine phosphate is used to treat malaria and to prevent it in people travelling to areas where malaria is common. It is also used for amoebic hepatitis and amoebic abscess, which are liver infections. In addition, it can be prescribed for discoid and systemic lupus erythematosus and for rheumatoid arthritis. Your doctor will decide whether this medicine is suitable for your condition and how it should be taken.

How to use Nivaquine

Nivaquine Syrup is taken by mouth. The amount and how often it is taken will be decided by your doctor based on your age, weight and the condition being treated. Always follow the doctor's instructions exactly and do not change the amount on your own. If you miss a dose, ask your doctor or pharmacist what to do. Do not stop the course early without medical advice, even if you feel better.

Side effects of Nivaquine

Most people tolerate chloroquine well at the doses prescribed. Some may experience headache or stomach upset, which are usually not serious. With long-term use at high doses, more serious effects can occur, including skin rashes, hair loss, difficulty focusing the eyes, blurred vision, and rarely blood problems such as low platelet or white cell counts. Long-term use may also cause eye damage, so regular eye checks may be needed. Tell your doctor if you notice any unusual symptoms.

Safety and precautions

Before taking Nivaquine Syrup, tell your doctor if you have liver problems, porphyria, or any other health condition, and about all other medicines you take. This medicine is not absolutely contraindicated, but it should be used with caution in certain patients. If you are pregnant or planning pregnancy, discuss with your doctor, as use during pregnancy should be avoided unless the doctor judges the benefit outweighs the risk. Patients on long-term or high-dose treatment may need regular eye examinations. Always ask your doctor or pharmacist before starting or stopping this medicine.

Frequently asked questions

What does the generic name chloroquine phosphate mean?

Chloroquine phosphate is the active substance in Nivaquine Syrup. It is an anti-malarial medicine that works against the malaria parasite in the blood. The phosphate refers to the salt form used in the medicine. Your doctor or pharmacist can explain more about how it works.

What is Nivaquine Syrup used for and what kind of medicine is it?

Nivaquine Syrup is used to treat and prevent malaria, and also for amoebic liver infections, lupus and rheumatoid arthritis. It is an anti-malarial medicine. The doctor will decide if it is right for your condition and how it should be taken.

How should I store Nivaquine Syrup?

Store Nivaquine Syrup at room temperature in a dry place, away from light. Keep it out of the reach of children. Do not use it after the expiry date printed on the pack. If you are unsure about storage, ask your pharmacist.

Can I take Nivaquine Syrup during pregnancy?

Use during pregnancy should be avoided if possible. If you are pregnant or planning pregnancy, tell your doctor. They will decide whether the benefit outweighs the risk. Do not start or stop this medicine without medical advice.

Also available as

250 mg (Tablet)

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.